U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07628985) titled 'BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes' on May 24.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of Bofanglutide (GZR18) compared with Semaglutide in Latin American adults with type 2 diabetes mellitus who have inadequate glycemic control while receiving stable metformin monotherapy. The main questions it aims to answer are:
Does Bofanglutide (GZR18) provide glycemic control comparable to Semaglutide based on changes in HbA1c? Is Bofanglutide (GZR18) safe and well tolerated in the study population? Can participants achieve glycemic targets and improve metabolic outcom...